Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand
This study has been completed.
Sponsor:
AstraZeneca
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00800904
First received: December 1, 2008
Last updated: December 2, 2010
Last verified: December 2010
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | December 1, 2008 | ||||||||
| Last Updated Date | December 2, 2010 | ||||||||
| Start Date ICMJE | May 2009 | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Current Primary Outcome Measures ICMJE |
Asthma control test [ Time Frame: On the survey date ] [ Designated as safety issue: No ] | ||||||||
| Original Primary Outcome Measures ICMJE |
Thai asthma control test [ Time Frame: On the survey date ] [ Designated as safety issue: No ] | ||||||||
| Change History | Complete list of historical versions of study NCT00800904 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE |
Asthma control in mild, moderate and severe persistent asthma patients [ Time Frame: On the survey date ] [ Designated as safety issue: No ] | ||||||||
| Original Secondary Outcome Measures ICMJE |
Peak expiratory flow rate [ Time Frame: Collect from medical records on the survey date ] [ Designated as safety issue: No ] | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Asthma Control Among Patients Receiving Inhaled Corticosteroids in Thailand | ||||||||
| Official Title ICMJE | Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand | ||||||||
| Brief Summary | The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored. |
||||||||
| Detailed Description | Not Provided | ||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | Time Perspective: Retrospective | ||||||||
| Target Follow-Up Duration | Not Provided | ||||||||
| Biospecimen | Not Provided | ||||||||
| Sampling Method | Non-Probability Sample | ||||||||
| Study Population | Patient aged 12 years and older who established persistent asthma and currently treated with any inhaled corticosteroid for 3 months or longer. |
||||||||
| Condition ICMJE | Asthma | ||||||||
| Intervention ICMJE | Not Provided | ||||||||
| Study Group/Cohort (s) | Not Provided | ||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Completed | ||||||||
| Estimated Enrollment ICMJE | 1210 | ||||||||
| Completion Date | November 2009 | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Both | ||||||||
| Ages | 12 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||||||
| Location Countries ICMJE | Thailand | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT00800904 | ||||||||
| Other Study ID Numbers ICMJE | NIS-RTH-DUM-2008/1 | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| Responsible Party | Thanu Komolsai, MD, Medical Advisor, AstraZeneca (Thailand) Ltd. | ||||||||
| Study Sponsor ICMJE | AstraZeneca | ||||||||
| Collaborators ICMJE | Not Provided | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | AstraZeneca | ||||||||
| Verification Date | December 2010 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||